FDA Guidelines on Usage of Stem Cells in Medicines


Instructor: Thomas Webster
Product ID: 704495

  • Duration: 120 Min
This training program will discuss stem cell sources and how to control stem cell differentiation, technologies (FDA and non-FDA) that exist in stem cell technologies, and the future directions and opportunities that exist for stem cell technologies.
Purchase option for this webinar is currently unavailable. Please contact our Customer Care for more info.


Customer Care

Fax: +1-650-362-2367

Email: [email protected]

Read Frequently Asked Questions

Why Should You Attend:

Stem cells harness the power to differentiate into numerous cells upon stimulation. This has led to their wide exploration across all of medicine, including high risk diseases. Of course, significant scientific breakthroughs in the use of stem cells to prevent, diagnose, and treat numerous diseases has caused numerous start-up companies to form. Despite such promise, the FDA has yet to approve stem cell therapies for a wide range of diseases, except cord blood-derived hematopoietic progenitor cells for certain indications.

This webinar will provide a historical context for the use of stem cells in medicine, where the field has been and where it is going. It will also provide few examples of FDA approved use of stem cells in medicine and what is needed for the stem cell field to progress.

Learning Objectives:

At the end of this course, attendees will have a better appreciation for:

  • Stem cell sources and how to control stem cell differentiation
  • What technologies (FDA and non-FDA) exist in stem cell technologies
  • What future directions and opportunities exist for stem cell technologies

Areas Covered in the Webinar:

  • Fundamentals of stem cells
    • What is all the excitement about
    • How to control stem cell differentiation
    • Sources of stem cells
    • Incorporating stem cells into biomaterials
    • Avoiding immune system clearance of stem cells
  • FDA regulatory approvals for the use of stem cells in medicine
    • Currently approved use of stem cells in medicine
    • FDA guidance documents for stem cell technologies
    • Global approval of stem cell technologies
  • Future thoughts on approaches for regulatory approval of stem cell technologies
    • Remaining hurdles
    • Outlook for new technologies

Who Will Benefit:

  • Scientists
  • Industry personnel
  • Students (all levels)
  • Patent lawyers
  • Clinicians
  • All persons with an interest in stem cell technologies

Instructor Profile:

Thomas J. Webster has degrees in chemical engineering from the University of Pittsburgh (B.S., 1995) and in biomedical engineering from Rensselaer Polytechnic Institute (M.S., 1997; Ph.D., 2000). In his 15 years in academics, Prof. Webster has graduated/supervised over 109 visiting faculty, clinical fellows, post-doctoral students, and thesis completing B.S., M.S., and Ph.D. students. To date, his lab group has generated over 9 textbooks, 48 book chapters, 306 invited presentations, at least 403 peer-reviewed literature articles (222) and/or conference proceedings (181), at least 567 conference presentations, and 32 provisional or full patents. Some of these patents led to the formation of 9 companies.

His research on nanomedicine has received attention in media publications including MSNBC, NBC Nightly News, PBS DragonFly TV, ABC Nightly News via the Ivanhoe Medical Breakthrough Segment, Fox News, and the Weather Channel. His work has been on display at the London and Boston Science Museums. He is the founding editor-in-chief of the International Journal of Nanomedicine, has helped organize 22 conferences emphasizing nanotechnology in medicine, and has organized over 53 symposia at numerous conferences emphasizing biological interactions with nanomaterials. He also chaired the 2011 Annual Biomedical Engineering Society Meeting and has organized numerous symposia for MRS, AIChE, and ASME conferences.

Prof. Webster has received numerous honors including, but not limited to 2013 Fellow, Biomedical Engineering Society and 2014 Fellow, Ernst Strugmann. He currently serves as the director of the Indo-U.S. Center for Biomaterials for Healthcare which serves to catalyze research between the U.S. and India in the area of biomaterial science with over 20 participating universities and industries. He was also recently elected president of the U.S. Society for Biomaterials.

Follow us :



Refund Policy

Our refund policy is governed by individual products and services refund policy mentioned against each of offerings. However in absence of specific refund policy of an offering below refund policy will be effective.
Registrants may cancel up to two working days prior to the course start date and will receive a letter of credit to be used towards a future course up to one year from date of issuance. ComplianceOnline would process/provide refund if the Live Webinar has been cancelled. The attendee could choose between the recorded version of the webinar or refund for any cancelled webinar. Refunds will not be given to participants who do not show up for the webinar. On-Demand Recordings can be requested in exchange. Webinar may be cancelled due to lack of enrolment or unavoidable factors. Registrants will be notified 24hours in advance if a cancellation occurs. Substitutions can happen any time. On-Demand Recording purchases will not be refunded as it is available for immediate streaming. However if you are not able to view the webinar or you have any concern about the content of the webinar please contact us at below email or by call mentioning your feedback for resolution of the matter. We respect feedback/opinions of our customers which enables us to improve our products and services. To contact us please email [email protected] call +1-888-717-2436 (Toll Free).




6201 America Center Drive Suite 240, San Jose, CA 95002, USA

Follow Us

facebook twitter linkedin youtube


Copyright © 2021 ComplianceOnline.com MetricStream
Our Policies: Terms of use | Privacy

PAYMENT METHOD: 100% Secure Transaction

payment method